Nuveen Asset Management, LLC Kymera Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 143,225 shares of KYMR stock, worth $4.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

143,225

Previous 140,187 2.17%

Holding current value

$4.54 Million

Previous $6.64 Million 13.17%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$39.06 - $51.84 $118,664 - $157,489	3,038 Added 2.17%	143,225 $5.76 Million
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $12,033 - $20,907	399 Added 0.29%	140,187 $6.64 Million
Q2 2024 Aug 09, 2024	BUY	$29.85 - $39.42 $1.31 Million - $1.73 Million	43,793 Added 45.62%	139,788 $4.17 Million
Q1 2024 May 13, 2024	SELL	$22.9 - $43.57 $935,029 - $1.78 Million	-40,831 Reduced 29.84%	95,995 $3.86 Million
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $460,323 - $1.13 Million	41,962 Added 44.23%	136,826 $3.48 Million
Q3 2023 Nov 14, 2023	SELL	$13.9 - $23.88 $13,983 - $24,023	-1,006 Reduced 1.05%	94,864 $1.32 Million
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $415,094 - $647,102	-18,531 Reduced 16.2%	95,870 $2.2 Million
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $233,098 - $363,630	-9,384 Reduced 7.58%	114,401 $3.39 Million
Q4 2022 Feb 14, 2023	SELL	$19.57 - $30.92 $310,184 - $490,082	-15,850 Reduced 11.35%	123,785 $3.09 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $268,714 - $440,403	12,851 Added 10.14%	139,635 $3.04 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $276,269 - $831,937	19,552 Added 18.23%	126,784 $2.5 Million
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $129,692 - $237,634	-3,674 Reduced 3.31%	107,232 $4.35 Million
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $302,205 - $396,965	-6,055 Reduced 5.18%	110,906 $5.83 Million
Q3 2021 Nov 12, 2021	SELL	$47.8 - $66.66 $952,176 - $1.33 Million	-19,920 Reduced 14.55%	116,961 $7.36 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $3.03 Million - $5.06 Million	97,387 Added 246.59%	136,881 $6.64 Million
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $23,558 - $56,489	661 Added 1.7%	39,494 $1.53 Million
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $1.09 Million - $3.41 Million	38,833 New	38,833 $2.41 Million

Others Institutions Holding KYMR

# of Institutions

186

Shares Held

65.6M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.73B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Kymera Therapeutics, Inc. Transaction History